Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Giglio

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
Anticancer Research|February 11, 2015
Mechanisms and clinical significance of histone deacetylase inhibitors: epigenetic glioblastoma therapyPhilip Lee, Ben Murphy, Rickey Miller, et al.
Neurochemical Research|January 10, 2012
Drug resistance in glioblastoma: a mini reviewCatherine P Haar, Preetha Hebbar, Gerald C Wallace, et al.
Journal of Neuroinflammation|March 14, 2026
Tumor immunogenicity shapes CNS immune niches and CD8⁺ T cell fate in glioblastomaSuman Asalla, Omar Santiagonunez Ahumada, Jordan E Krull, et al.
Metabolic Brain Disease|April 2, 2013
Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastomaGerald C Wallace, Yaenette N Dixon-Mah, W Alex Vandergrift, et al.
Journal of Neuro-Oncology|June 12, 2013
Multi-targeted DATS prevents tumor progression and promotes apoptosis in ectopic glioblastoma xenografts in SCID mice via HDAC inhibitionGerald C Wallace, Catherine P Haar, W Alex Vandergrift, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2026
BNIP3-mTOR Signaling Mediates Resistance to MET Inhibition in GlioblastomaYunzhan Li, Hanif Khan, Seyma Demirsoy, et al.
Cancer Chemotherapy and Pharmacology|September 14, 2018
Single agent efficacy of the HDAC inhibitor DATS in preclinical models of glioblastomaArabinda Das, Fraser Henderson, Stephen Lowe, et al.
Biomedicines|July 27, 2022
Small Molecules and Immunotherapy Agents for Enhancing Radiotherapy in GlioblastomaJennifer K Matsui, Haley K Perlow, Alex R Ritter, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 13, 2015
A novel component from citrus, ginger, and mushroom family exhibits antitumor activity on human meningioma cells through suppressing the Wnt/β-catenin signaling pathwayArabinda Das, Rickey Miller, Philip Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|February 24, 2025
Boswellia Serrata for Cerebral Radiation Necrosis After Radiosurgery for Brain MetastasesRituraj Upadhyay, Ahmed Nader Mohammed Elguindy, Laura Salts, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Anticancer Research|February 11, 2015
Mechanisms and clinical significance of histone deacetylase inhibitors: epigenetic glioblastoma therapyPhilip Lee, Ben Murphy, Rickey Miller, et al.
Neurochemical Research|January 10, 2012
Drug resistance in glioblastoma: a mini reviewCatherine P Haar, Preetha Hebbar, Gerald C Wallace, et al.
Journal of Neuroinflammation|March 14, 2026
Tumor immunogenicity shapes CNS immune niches and CD8⁺ T cell fate in glioblastomaSuman Asalla, Omar Santiagonunez Ahumada, Jordan E Krull, et al.
Metabolic Brain Disease|April 2, 2013
Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastomaGerald C Wallace, Yaenette N Dixon-Mah, W Alex Vandergrift, et al.
Journal of Neuro-Oncology|June 12, 2013
Multi-targeted DATS prevents tumor progression and promotes apoptosis in ectopic glioblastoma xenografts in SCID mice via HDAC inhibitionGerald C Wallace, Catherine P Haar, W Alex Vandergrift, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2026
BNIP3-mTOR Signaling Mediates Resistance to MET Inhibition in GlioblastomaYunzhan Li, Hanif Khan, Seyma Demirsoy, et al.
Cancer Chemotherapy and Pharmacology|September 14, 2018
Single agent efficacy of the HDAC inhibitor DATS in preclinical models of glioblastomaArabinda Das, Fraser Henderson, Stephen Lowe, et al.
Biomedicines|July 27, 2022
Small Molecules and Immunotherapy Agents for Enhancing Radiotherapy in GlioblastomaJennifer K Matsui, Haley K Perlow, Alex R Ritter, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 13, 2015
A novel component from citrus, ginger, and mushroom family exhibits antitumor activity on human meningioma cells through suppressing the Wnt/β-catenin signaling pathwayArabinda Das, Rickey Miller, Philip Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|February 24, 2025
Boswellia Serrata for Cerebral Radiation Necrosis After Radiosurgery for Brain MetastasesRituraj Upadhyay, Ahmed Nader Mohammed Elguindy, Laura Salts, et al.
Pageof 10